<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR207.html">Part 207
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 207.3  Definitions.
                            </h3>
                            <p class="depth1"><em>(a)</em> The following definitions apply to this part:</p><p class="depth2"><em>(1)</em> Act means the Federal Food, Drug, and Cosmetic Act approved June  25, 1938 (52 Stat. 1040 et seq., as amended (21 U.S.C. 301-392)), except  as otherwise provided.</p><p class="depth2"><em>(2)</em> respectively.</p><p class="depth2"><em>(3)</em> Any material change includes but is not limited to any change in  the name of the drug, any change in the identity or quantity of the  active ingredient(s), any change in the identity or quantity of the  inactive ingredient(s) where quantitative listing of all ingredients is  required by Sec. 207.31(a)(2), any significant change in the labeling  of a prescription drug, and any significant change in the label or  package insert of an over-the-counter drug. Changes that are not  significant include changes in arrangement or printing or changes of an  editorial nature.</p><p class="depth2"><em>(4)</em> Bulk drug substance means any substance that is represented for  use in a drug and that, when used in the manufacturing, processing, or  packaging of a drug, becomes an active ingredient or a finished dosage  form of the drug, but the term does not include intermediates used in  the synthesis of such substances.</p><p class="depth2"><em>(5)</em> Commercial distribution means any distribution of a human drug  except for investigational use under part 312 of this chapter, and any  distribution of an animal drug or animal feed bearing or containing an  animal drug for noninvestigational uses, but the term does not include  internal or interplant   transfer of a bulk drug substance between registered establishments  within the same parent, subsidiary, and/or affiliate company. For  foreign establishments, the term ``commercial distribution'' shall have  the same meaning except that the term shall not include distribution of  any drug that is neither imported nor offered for import into the United  States.</p><p class="depth2"><em>(6)</em> Drug product salvaging means the act of segregating drug  products that may have been subjected to improper storage conditions,  such as extremes in temperature, humidity, smoke, fumes, pressure, age,  or radiation, for the purpose of returning some or all of the products  to the marketplace.</p><p class="depth2"><em>(7)</em> Establishment means a place of business under one management at  one general physical location. The term includes, among others,  independent laboratories that engage in control activities for a  registered drug establishment (e.g., consulting laboratories),  manufacturers of medicated feeds and of vitamin products that are drugs  in accordance with section 201(g) of the act, human blood donor centers,  and animal facilities used for the production or control testing of  licensed biologicals, and establishments engaged in drug product  salvaging.</p><p class="depth2"><em>(8)</em> Manufacturing or processing means the manufacture, preparation,  propagation, compounding, or processing of a drug or drugs as used in  section 510 of the act and is the making by chemical, physical,  biological, or other procedures of any articles that meet the definition  of drugs in section 201(g) of the act. The term includes manipulation,  sampling, testing, or control procedures applied to the final product or  to any part of the process. The term also includes repackaging or  otherwise changing the container, wrapper, or labeling of any drug  package to further the distribution of the drug from the original place  of manufacture to the person who makes final delivery or sale to the  ultimate consumer.</p><p class="depth2"><em>(9)</em> Representative sampling of advertisements means typical  advertising material (excluding labeling as determined in Sec. 202.1(l)  (1) and (2)) that gives a balanced picture of the promotional claims  used for the drug, e.g., if more than one medical journal advertisement  is used but the promotional content is essentially identical, only one  need be submitted.</p><p class="depth2"><em>(10)</em> Representative sampling of any other labeling means typical  labeling material (excluding labels and package inserts) that gives a  balanced picture of the promotional claims used for the drug, e.g., if  more than one brochure is used but the promotional content is  essentially identical, only one need be submitted.</p><p class="depth2"><em>(11)</em> United States agent means a person residing or maintaining a  place of business in the United States whom a foreign establishment  designates as its agent. This definition excludes mailboxes, answering  machines or services, or other places where an individual acting as the  foreign establishment's agent is not physically present.</p><p class="depth1"><em>(b)</em> The definitions and interpretations of terms in sections 201,  502(e), and 510 of the act apply to the use of terms in this part.  [45 FR 38043, June 6, 1980, as amended at 55 FR 11576, Mar. 29, 1990; 66  FR 59156, Nov. 27, 2001]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
